Loading page...

Back
PAR-27-053 Open
Send to:
National Institutes of Health United States

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Open Health Posted 31 Aug 2026
Deadline 16 Jun 2028, 00:00 625 days left

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
PAR-27-053
Funding programme
Health
Funding instrument
Grant
Cost sharing
Not required
Region
United States
Source
Grants.gov (US Federal)

Description

This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. For projects not requiring a phased…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) National Institutes of Health Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) National Institutes of Health Research Grants in Clinical Informatics (R01 Clinical Trial Optional) National Institutes of Health
Operating Grant: Human Frontier Science Program - Research Grants Canadian Institutes of Health Research Operating Grant: End Diabetes Award Canadian Institutes of Health Research Other: One Health Antimicrobial Resistance Research Network Canadian Institutes of Health Research

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top